pathogen detection
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
Despite recent struggles, the firm remains optimistic about its position as the first and only direct-from-blood sepsis test system.
University of Pittsburgh researchers showed that real-time pathogen whole-genome sequencing can help curb healthcare-associated infections within a hospital.
Biotia Raises $8M in Series A Financing
The New York-based startup said the funding will be used to expand its technical capabilities, regulatory compliance, and marketing reach.
Illumina Acquires IDbyDNA
The firms have had an alliance for the past two years and market a respiratory pathogen panel.
Mar 11, 2020
SARS-CoV-2 Detected in Multiple Sample Types
Dec 10, 2019
Biotia Raises $2.4M in Seed Financing
Apr 30, 2019